Hansen Medical (HNSN): Opco ups tgt to $52 from $36
Tweet
Share
E-mailGet Alerts HNSN Hot Sheet
Price: $3.99 --0%
Rating Summary:
1 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Rating Summary:
1 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Join SI Premium – FREE
From Notable Calls
Oppenheimer is out positive on Hansen Medical (NASDAQ: HNSN) upping their tgt to $52 from $36 after meeting with management last week. The firm notes they continue to see extremely strong interest in the Sensei system. One hundred one procedures were completed in the September quarter (up from 48 from May through mid August). It seems that at the Cleveland Clinic one physician prefers the Stereotaxis (NASDAQ: STXS) system, several physicians prefer the Sensei, and several use both systems. It is their view that so long as the preference is equal or better, that up front price will be the deciding factor. Firm expects Hansen's ramp to accelerate.
Additionally, they have learned that the production holding back system installations is actually the production of the disposables. Hansen expects to be able to meet demand with its new production facility in 2008. Firm has spoken to many cardiologists who truly appreciate the significance remote navigation will have on medicine in the future.
On valuation side the firm will now use 10x in line with Stereotaxis even though they believe Hansen will have the faster ramp.
Reits Buy.
Notablecalls: Expect to see strong buy interest in HNSN as the stock is a mo-mo darling and OpCo's tgt represents the new Street high.
For more calls go to http://notablecalls.blogspot.com/
Oppenheimer is out positive on Hansen Medical (NASDAQ: HNSN) upping their tgt to $52 from $36 after meeting with management last week. The firm notes they continue to see extremely strong interest in the Sensei system. One hundred one procedures were completed in the September quarter (up from 48 from May through mid August). It seems that at the Cleveland Clinic one physician prefers the Stereotaxis (NASDAQ: STXS) system, several physicians prefer the Sensei, and several use both systems. It is their view that so long as the preference is equal or better, that up front price will be the deciding factor. Firm expects Hansen's ramp to accelerate.
Additionally, they have learned that the production holding back system installations is actually the production of the disposables. Hansen expects to be able to meet demand with its new production facility in 2008. Firm has spoken to many cardiologists who truly appreciate the significance remote navigation will have on medicine in the future.
On valuation side the firm will now use 10x in line with Stereotaxis even though they believe Hansen will have the faster ramp.
Reits Buy.
Notablecalls: Expect to see strong buy interest in HNSN as the stock is a mo-mo darling and OpCo's tgt represents the new Street high.
For more calls go to http://notablecalls.blogspot.com/
You May Also Be Interested In
- Advance Auto Parts (AAP) PT Lowered to $48 at DA Davidson Following 25% Selloff Post Q2 Results
- Ferrovial SA (FER:SM) (FRRVF) Reiterated at Buy by UBS on Winning Bid For Tennessee Project
- Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
Create E-mail Alert Related Categories
Analyst Comments, ContributorsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
